Drug General Information
Drug ID
D0U7VU
Former ID
DNCL003643
Drug Name
MLN0264
Indication Gastrointestinal cancers [ICD9: 150-159; ICD10:C15-C26] Phase 2 [524850]
Company
Millenium; The Takeda oncology company
Target and Pathway
Target(s) Guanylyl cyclase C Target Info Modulator [549681]
References
Ref 524850ClinicalTrials.gov (NCT02202759) A Study of MLN0264 in Patients With Cancer of the Stomach or Gastroesophageal Junction. U.S. National Institutes of Health.
Ref 549681J Clin Oncol 31, 2013 (suppl; abstr TPS3646).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.